12:00 AM
 | 
Jun 11, 2001
 |  BioCentury  |  Finance

Cardio space

Cardio space

Company Most mature cardiovascular product(s) Phase Indication 6/8 market cap (M)
Texas Bio (TXB) Argatroban anticoagulant Mkt-US Prevent or treat thrombosis associated with heparin-induced thrombocytopenia $380.2M
Medicines Co. (MDCO) Angiomax (Hirulog) anticoagulant peptide thrombin inhibitor Mkt-US, MAA Angioplasty for unstable angina $541.9M
Scios (SCIO)

Read the full 307 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >